This spotlight examines whether adolescents aged 12 to 17 who had moderate or symptoms of generalized anxiety disorder (GAD) in the past month were more likely to use some substances than adolescents who had no or minimal symptoms of GAD. Estimates are based on data from the 2024 NSDUH.